MedTrace Logo

Immunogenicity of Cholera Vaccine in Children With IBD

NCT03998449 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2020-05-20

No results posted yet for this study

Summary

Assessment of the immunogenicity and safety of immunization against cholera in children with inflammatory bowel disease.

Conditions

  • Cholera
  • Inflammatory Bowel Diseases

Interventions

BIOLOGICAL

Vaccination against cholera

Participants will receive two doses of an oral cholera vaccine with an interval of 2-4 weeks.

Sponsors & Collaborators

  • Medical University of Gdansk

    collaborator OTHER

  • Medical University of Warsaw

    lead OTHER

Principal Investigators

  • Aleksandra Banaszkiewicz, MD, PhD · Medical University of Warsaw

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
6 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-30
Primary Completion
2020-04-01
Completion
2020-05-01

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03998449 on ClinicalTrials.gov